No Data
No Data
VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants
Express News | VolitionRX Shares Are Trading Higher After the Company Announced a Study Showed Its Nu.Q Lung Cancer Test Achieved 92% Sensitivity and 89% Positive Predictive Value in Differentiating Malignant From Benign Pulmonary Nodules
Express News | VolitionRX Announces Pricing of up to $1.9 Million Registered Direct Offering
VolitionRx Announces Pricing of up to $1.9 Million Registered Direct Offering
Benchmark Co. Maintains VolitionRX(VNRX.US) With Hold Rating
VolitionRX (VNRX) Gets a Hold From Benchmark Co.
105283537 : High outflow stocks
Stock_Drift OP 105283537 : Sure.
105283537 : It’s too risky to get it and volume in k not m
Stock_Drift OP 105283537 : Ok.
MindOverMatter : Was telling my brother yesterday inverse head n shoulders on the 4hr
View more comments...